Related references
Note: Only part of the references are listed.Fatty Acid Synthase Inhibition by Amentoflavone Suppresses HER2/neu (erbB2) Oncogene in SKBR3 Human Breast Cancer Cells
Jin Sun Lee et al.
PHYTOTHERAPY RESEARCH (2013)
Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer
James S. Duncan et al.
CELL (2012)
Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies
Michael Steckel et al.
CELL RESEARCH (2012)
HSP32 (HO-1) inhibitor, copoly(styrene-maleic acid)-zinc protoporphyrin IX, a water-soluble micelle as anticancer agent: In vitro and in vivo anticancer effect
Jun Fang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2012)
Inhibition of Heme Oxygenase-1 Enhances the Radiosensitivity in Human Nonsmall Cell Lung Cancer A549 Cells
Wenyi Zhang et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2011)
Nilotinib and MEK Inhibitors Induce Synthetic Lethality through Paradoxical Activation of RAF in Drug-Resistant Chronic Myeloid Leukemia
Leisl M. Packer et al.
CANCER CELL (2011)
Vimentin in cancer and its potential as a molecular target for cancer therapy
Arun Satelli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Mass spectrometry-based functional proteomics of poly(ADP-ribose) polymerase-1
Emilie Pic et al.
EXPERT REVIEW OF PROTEOMICS (2011)
Synthetic lethality: General principles, utility and detection using genetic screens in human cells
Sebastian M. B. Nijman
FEBS LETTERS (2011)
Subcellular Tissue Proteomics of Hepatocellular Carcinoma for Molecular Signature Discovery
Yong-Yook Lee et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance
Ye-Hong Kuang et al.
BIOCHEMICAL PHARMACOLOGY (2010)
PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration
Ganta Vijay Chaitanya et al.
CELL COMMUNICATION AND SIGNALING (2010)
Exploration of synthetic lethal interactions as cancer drug targets
Hendrik J. Kuiken et al.
FUTURE ONCOLOGY (2010)
Synthetic lethal interactions for the development of cancer therapeutics: biological and methodological advancements
Shinji Mizuarai et al.
HUMAN GENETICS (2010)
Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)
Mariacristina Di Marco et al.
ONCOLOGY REPORTS (2010)
Phenotype and Genotype of Pancreatic Cancer Cell Lines
Emily L. Deer et al.
PANCREAS (2010)
Substrate-dependent bidirectional modulation of P-glycoprotein-mediated drug resistance by erlotinib
Kohji Noguchi et al.
CANCER SCIENCE (2009)
Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells
Claudia Scholl et al.
CELL (2009)
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
Ji Luo et al.
CELL (2009)
Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo
Philipp Nuhn et al.
MOLECULAR CANCER (2009)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
Statistical similarities between transcriptomics and quantitative shotgun proteomics data
Norman Pavelka et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Pancreatic Cancer: A Review and Update
Elizabeth Prechtel Dunphy
CLINICAL JOURNAL OF ONCOLOGY NURSING (2008)
Erlotinib (Tarceva, OSI-774) antagonizes ATP-bInding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance
Zhi Shi et al.
CANCER RESEARCH (2007)
Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice
Kaeko Hirai et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Pancreatic cancer: a review of recent advances
Florian Eckel et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment
PO Berberat et al.
CLINICAL CANCER RESEARCH (2005)
The concept of synthetic lethality in the context of anticancer therapy
WG Kaelin
NATURE REVIEWS CANCER (2005)
A power law global error model for the identification of differentially expressed genes in microarray data
N Pavelka et al.
BMC BIOINFORMATICS (2004)
Fatty acid synthase: A metabolic oncogene in prostate cancer?
A Baron et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Apoptosis-inducing factor (AIF):: key to the conserved caspase-independent pathways of cell death?
C Candé et al.
JOURNAL OF CELL SCIENCE (2002)
Controlling the false discovery rate in behavior genetics research
Y Benjamini et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
Share Paper
